{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T20:41:44Z","timestamp":1791492104743,"version":"4.3.4"},"reference-count":40,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Small bowel capsule endoscopy (SBCE) is an essential tool for evaluation of small bowel (SB) Crohn disease (CD). Fecal calprotectin (FC) represents an important biomarker of intestinal inflammation, widely used in ulcerative colitis and CD. Our aim was to evaluate the role of FC for diagnosing inflammatory activity in patients with isolated SB CD and how it correlates with SBCE findings.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>This is a retrospective study conducted in a tertiary inflammatory bowel disease referral center that included patients with SB CD who underwent SBCE between January 2017 and February 2023. FC value was obtained from the closest stool examination to SBCE.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>One hundred ninety-six patients were included: 123 were women (63%) with a mean age of 44.2 years. In the SBCE, 127 (65%) patients had a Lewis Score \u2265135 and, among the 94 patients with FC &gt;200 \u03bcg\/g, 23 had LS &lt;135, 36 had LS between 135 and 790, and 35 had LS \u2265790. FC levels were predictive of endoscopic lesions in SBCE, with significant correlation between FC level and total LS (Pearson correlation coefficient 0.43, <jats:italic toggle=\"yes\">P<\/jats:italic>&lt;.001). The sensitivity and specificity were calculated for each cut-off value being respectively 78% and 45% for FC = 100 \u03bcg\/g, 69% and 59% for FC = 150 \u03bcg\/g and 67% and 67% for FC = 200 \u03bcg\/g.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>FC showed moderate correlation with endoscopic findings in SBCE in SB CD. It is, therefore, a reasonable marker for predicting significant inflammatory lesions in SBCE; however, none of the cut-off had a high sensitivity or specificity.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/j.pbj.0000000000000263","type":"journal-article","created":{"date-parts":[[2024,8,9]],"date-time":"2024-08-09T13:27:40Z","timestamp":1723210060000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Fecal calprotectin as an inflammatory biomarker in small bowel Crohn disease"],"prefix":"10.1097","volume":"9","author":[{"given":"Maria I.","family":"Sousa","sequence":"first","affiliation":[{"name":"Gastroenterology Department, Centro Hospitalar Universit\u00e1rio de S\u00e3o Jo\u00e3o, Porto, Portugal"},{"name":"Faculty of Medicine, University of Porto, Porto, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuel","family":"Dias","sequence":"additional","affiliation":[{"name":"Gastroenterology Department, Centro Hospitalar Universit\u00e1rio de S\u00e3o Jo\u00e3o, Porto, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patr\u00edcia","family":"Andrade","sequence":"additional","affiliation":[{"name":"Gastroenterology Department, Centro Hospitalar Universit\u00e1rio de S\u00e3o Jo\u00e3o, Porto, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guilherme","family":"Macedo","sequence":"additional","affiliation":[{"name":"Gastroenterology Department, Centro Hospitalar Universit\u00e1rio de S\u00e3o Jo\u00e3o, Porto, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,7]]},"reference":[{"key":"R1-20240809","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1053\/j.gastro.2011.10.001","article-title":"Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review","volume":"142","author":"Molodecky","year":"2012","journal-title":"Gastroenterology"},{"key":"R2-20240809","first-page":"661","article-title":"Crohn's disease: diagnosis and management","volume":"98","author":"Veauthier","year":"2018","journal-title":"Am Fam Physician"},{"key":"R3-20240809","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1001\/jama.2020.18936","article-title":"Management of Crohn disease: a review","volume":"325","author":"Cushing","year":"2021","journal-title":"JAMA"},{"key":"R5-20240809","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1016\/S0140-6736(16)31711-1","article-title":"Crohn's disease","volume":"389","author":"Torres","year":"2017","journal-title":"Lancet"},{"key":"R6-20240809","first-page":"0416","article-title":"Crohn's disease","volume":"2011","author":"Mills","year":"2011","journal-title":"BMJ Clin Evid"},{"key":"R7-20240809","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/ajg.2018.27","article-title":"ACG clinical guideline: management of Crohn's disease in adults","volume":"113","author":"Lichtenstein","year":"2018","journal-title":"Am J Gastroenterol"},{"key":"R8-20240809","doi-asserted-by":"crossref","first-page":"732","DOI":"10.5009\/gnl20249","article-title":"Diagnostic accuracy of fecal calprotectin for the detection of small bowel Crohn's disease through capsule endoscopy: an updated meta-analysis and systematic review","volume":"15","author":"Jung","year":"2021","journal-title":"Gut Liver"},{"key":"R9-20240809","first-page":"211","article-title":"Fecal calprotectin as a biomarker of inflammatory lesions of the small bowel seen by videocapsule endoscopy","volume":"107","author":"Egea-Valenzuela","year":"2015","journal-title":"Rev Esp Enferm Dig"},{"key":"R10-20240809","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1097\/MEG.0b013e32832bab49","article-title":"Fecal calprotectin is a predictive marker of relapse in Crohn's disease involving the colon: a prospective study","volume":"22","author":"Kallel","year":"2010","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"R11-20240809","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1136\/gut.2005.082909","article-title":"The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications","volume":"55","author":"Satsangi","year":"2006","journal-title":"Gut"},{"key":"R12-20240809","doi-asserted-by":"crossref","first-page":"otaa040","DOI":"10.1093\/crocol\/otaa040","article-title":"A novel capsule endoscopic score for Crohn's disease","volume":"2","author":"Omori","year":"2020","journal-title":"Crohns Colitis 360."},{"key":"R13-20240809","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.crohns.2011.12.002","article-title":"Lewis Score: a useful clinical tool for patients with suspected Crohn's Disease submitted to capsule endoscopy","volume":"6","author":"Rosa","year":"2012","journal-title":"J Crohns Colitis"},{"key":"R14-20240809","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1159\/000527846","article-title":"Positioning and usefulness of biomarkers in inflammatory bowel disease","volume":"104","author":"Sakurai","year":"2023","journal-title":"Digestion"},{"key":"R15-20240809","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1093\/jcag\/gwaa009","article-title":"Fecal calprotectin, CRP and leucocytes in IBD patients: comparison of biomarkers with biopsy results","volume":"4","author":"Kyle","year":"2021","journal-title":"J Can Assoc Gastroenterol"},{"key":"R16-20240809","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1038\/ajg.2015.120","article-title":"C-reactive protein, fecal calprotectin, and stool lactoferrin for detection of endoscopic activity in symptomatic inflammatory bowel disease patients: a systematic review and meta-analysis","volume":"110","author":"Mosli","year":"2015","journal-title":"Am J Gastroenterol"},{"key":"R17-20240809","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1080\/10408363.2019.1619159","article-title":"Clinical value of fecal calprotectin","volume":"56","author":"Ricciuto","year":"2019","journal-title":"Crit Rev Clin Lab Sci"},{"key":"R18-20240809","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.3390\/diagnostics12092226","article-title":"Fecal calprotectin for small bowel Crohn's disease: is it a cutoff issue?","volume":"12","author":"Romero-Mascarell","year":"2022","journal-title":"Diagnostics (Basel)"},{"key":"R19-20240809","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1097\/MIB.0000000000001202","article-title":"Fecal calprotectin more accurately predicts endoscopic remission of Crohn's disease than serological biomarkers evaluated using balloon-assisted enteroscopy","volume":"23","author":"Kawashima","year":"2017","journal-title":"Inflamm Bowel Dis"},{"key":"R20-20240809","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1038\/ajg.2015.221","article-title":"Detection of small bowel mucosal healing and deep remission in patients with known small bowel Crohn's disease using biomarkers, capsule endoscopy, and imaging","volume":"110","author":"Kopylov","year":"2015","journal-title":"Am J Gastroenterol"},{"key":"R21-20240809","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1080\/00365521.2016.1253769","article-title":"A prospective study of fecal calprotectin and lactoferrin as predictors of small bowel Crohn's disease in patients undergoing capsule endoscopy","volume":"52","author":"Bar-Gil Shitrit","year":"2017","journal-title":"Scand J Gastroenterol"},{"key":"R22-20240809","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1093\/ecco-jcc\/jjv150","article-title":"Endoscopic factors influencing fecal calprotectin value in Crohn's disease","volume":"9","author":"Goutorbe","year":"2015","journal-title":"J Crohns Colitis"},{"key":"R23-20240809","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1007\/s00535-016-1182-4","article-title":"Fecal calprotectin: its scope and utility in the management of inflammatory bowel disease","volume":"51","author":"Ikhtaire","year":"2016","journal-title":"J Gastroenterol"},{"key":"R24-20240809","first-page":"14","article-title":"Fecal calprotectin: validation as a noninvasive measure of bowel inflammation in childhood inflammatory bowel disease","volume":"33","author":"Bunn","year":"2011","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"R25-20240809","doi-asserted-by":"crossref","first-page":"101602","DOI":"10.1016\/j.bpg.2019.02.004","article-title":"What is the role of C-reactive protein and fecal calprotectin in evaluating Crohn's disease activity?","volume":"38-39","author":"Ma","year":"2019","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"R26-20240809","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/ajg.2009.545","article-title":"Fecal calprotectin correlates more closely with the Simple Endoscopic Score for Crohn's disease (SES-CD) than CRP, blood leukocytes, and the CDAI","volume":"105","author":"Schoepfer","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"R27-20240809","article-title":"Crohn\u2019s disease","author":"Gaillard","year":"2009","journal-title":"Radiopaedia.org"},{"key":"R28-20240809","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s43162-024-00316-6","article-title":"The intestinal ultrasound role in inflammatory bowel disease in clinical practice and a critical appraisal of the current guidelines (mini-review)","volume":"36","author":"El-Nakeep","year":"2024","journal-title":"Egypt J Intern Med"},{"key":"R29-20240809","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1093\/ecco-jcc\/jjy113","article-title":"ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 1: initial diagnosis, monitoring of known IBD, detection of complications","volume":"13","author":"Maaser","year":"2019","journal-title":"J Crohns Colitis"},{"key":"R30-20240809","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/jgh3.12068","article-title":"Fecal calprotectin correlates with active colonic inflammatory bowel disease but not with small intestinal Crohn's disease activity","volume":"2","author":"Zittan","year":"2018","journal-title":"JGH Open"},{"key":"R31-20240809","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1097\/MEG.0000000000000692","article-title":"Fecal calprotectin for the prediction of small-bowel Crohn's disease by capsule endoscopy: a systematic review and meta-analysis","volume":"28","author":"Kopylov","year":"2016","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"R32-20240809","doi-asserted-by":"crossref","first-page":"694","DOI":"10.3109\/00365521.2011.560680","article-title":"Fecal calprotectin is equally sensitive in Crohn's disease affecting the small bowel and colon","volume":"46","author":"Jensen","year":"2011","journal-title":"Scand J Gastroenterol"},{"key":"R33-20240809","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1007\/s00535-012-0539-6","article-title":"Biopsy interpretation of colonic biopsies when inflammatory bowel disease is excluded","volume":"47","author":"Khor","year":"2012","journal-title":"J Gastroenterol"},{"key":"R35-20240809","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1093\/ibd\/izaa269","article-title":"Fecal calprotectin is highly effective to detect endoscopic ulcerations in Crohn's disease regardless of disease location","volume":"27","author":"Buisson","year":"2021","journal-title":"Inflamm Bowel Dis"},{"key":"R36-20240809","first-page":"193","article-title":"The diagnostic and predictive value of fecal calprotectin and capsule endoscopy for small-bowel Crohn's disease: a systematic review and meta-analysis","volume":"113","author":"Xiang","year":"2021","journal-title":"Rev Esp Enferm Dig"},{"key":"R37-20240809","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1097\/MIB.0000000000000404","article-title":"Fecal calprotectin in ileal Crohn's disease: relationship with magnetic resonance enterography and a pathology score","volume":"21","author":"Cerrillo","year":"2015","journal-title":"Inflamm Bowel Dis"},{"key":"R38-20240809","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1007\/s00384-022-04232-5","article-title":"Fecal calprotectin predicts endoscopic activity and mucosal healing of small bowel Crohn's disease evaluated by double-balloon endoscopy","volume":"37","author":"Han","year":"2022","journal-title":"Int J Colorectal Dis"},{"key":"R39-20240809","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1093\/ibd\/izy098","article-title":"Fecal calprotectin as a selection tool for small bowel capsule endoscopy in suspected Crohn\u2019s disease","volume":"24","author":"Monteiro","year":"2018","journal-title":"Inflamm Bowel Dis"},{"key":"R40-20240809","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1097\/MEG.0000000000000696","article-title":"The diagnostic accuracy of faecal calprotectin and small bowel capsule endoscopy and their correlation in suspected isolated small bowel Crohn\u2019s disease","volume":"28","author":"Hale","year":"2016","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"R41-20240809","doi-asserted-by":"crossref","first-page":"272","DOI":"10.3109\/00365521.2014.1003395","article-title":"Fecal calprotectin in patients with suspected small bowel disease\u2014a selection tool for small bowel capsule endoscopy?","volume":"50","author":"Olsen","year":"2015","journal-title":"Scand J Gastroenterol"},{"key":"R42-20240809","doi-asserted-by":"crossref","first-page":"561","DOI":"10.3109\/00365521.2011.551835","article-title":"Fecal calprotectin: a selection tool for small bowel capsule endoscopy in suspected IBD with prior negative bi-directional endoscopy","volume":"46","author":"Koulaouzidis","year":"2011","journal-title":"Scand J Gastroenterol"}],"container-title":["Porto Biomedical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/j.pbj.0000000000000263","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,9]],"date-time":"2024-08-09T13:28:04Z","timestamp":1723210084000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/j.pbj.0000000000000263"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":40,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/j.pbj.0000000000000263","relation":{},"ISSN":["2444-8664"],"issn-type":[{"value":"2444-8664","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"2024-05-14","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-07-14","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}